RIMONDI, Erika
Activation of PKC-e counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.
2009-01-01 Gonelli, A; Milani, D; Rimondi, Erika; Voltan, R; Grill, Vittorio; Celeghini, C.
Activation of PKC-epsilon counteracts maturation and apoptosis of HL-60 myeloid leukemic cells in response to TNF family members.
2009-01-01 Gonelli, A.; Milani, D.; Rimondi, Erika; Voltan, R.; Grill, Vittorio; Celeghini, Claudio
Activation of the p53 pathway down-regulates the osteoprotegerin expression and release by vascular endothelial cells
2008-01-01 Secchiero, P; Corallini, F; Rimondi, Erika; Chiaruttini, C; DI IASIO, Mg; Rustighi, Alessandra; DEL SAL, Giannino; Zauli, G.
C-Reactive protein downregulates TRAIL expression in human peripheral monocytes via an Egr-1-dependent pathway.
2013-01-01 P., Secchiero; Rimondi, Erika; M. G., di Iasio; C., Agnoletto; E., Melloni; I., Volpi; G., Zauli
Defibrotide impact on the acute GVHD disease incidence in pediatric hematopoietic stem cell transplant recipients
2023-01-01 Squillaci, Domenica; Marcuzzi, Annalisa; Rimondi, Erika; Riccio, Guglielmo; Barbi, Egidio; Zanon, Davide; Maximova, Natalia
Dexamethasone counteracts the anti-osteoclastic, but not the anti-leukemic, activity of TNF-related apoptosis inducing ligand (TRAIL).
2010-01-01 Zauli, G.; Rimondi, Erika; Celeghini, Claudio; Milani, D.; Secchiero, P.
Differential effects of chemotherapeutic drugs versus the MDM-2 antagonist nutlin-3 on cell cycle progression and induction of apoptosis in SKW6.4 lymphoblastoid B-cells.
2008-01-01 Barbarotto, E; Corallini, F; Rimondi, Erika; Fadda, R; Mischiati, C; Grill, Vittorio; Vaccarezza, M; Celeghini, Claudio
Fine tuning of protein kinase C (PKC) isoforms in cancer: shortening the distance from the laboratory to the bedside.
2011-01-01 Bosco, R.; Melloni, E.; Celeghini, Claudio; Rimondi, Erika; Vaccarezza, M.; Zauli, G.
GM-CSF exhibits anti-inflammatory activity on endothelial cells derived from chronic venous disease patients.
2013-01-01 V., Tisato; P., Secchiero; Rimondi, Erika; S., Gianesini; E., Menegatti; F., Casciano; P., Zamboni; G., Zauli
Human colostrum and breast milk contain high levels of TNF-related apoptosis-inducing ligand (TRAIL).
2013-01-01 R., Davanzo; G., Zauli; L., Monasta; L., Vecchi Brumatti; M. V., Abate; G., Ventura; Rimondi, Erika; P., Secchiero; S., Demarini
Hydrogen sulfide down-regulates the expression and release of osteoprotegerin (OPG) by vascular endothelial cells.
2012-01-01 Rimondi, Erika; di Iasio, M. G.; Gonelli, A.; Celeghini, Claudio; Secchiero, P.; Zauli, G.
Ibrutinib synergizes with MDM-2 inhibitors in promoting cytotoxicity in B chronic lymphocytic leukemia
2016-01-01 Voltan, Rebecca; Rimondi, Erika; Melloni, Elisabetta; Rigolin, Gian Matteo; Casciano, Fabio; Arcidiacono, Maria Vittoria; Celeghini, Claudio; Cuneo, Antonio; Zauli, Giorgio; Secchiero, Paola
Inhibitory effect of natural anti-inflammatory compounds on cytokines released by chronic venous disease patient-derived endothelial cells.
2013-01-01 V., Tisato; G., Zauli; Rimondi, Erika; S., Gianesini; L., Brunelli; E., Menegatti; P., Zamboni; P., Secchiero
Kinetic Profiles of Inflammatory Mediators in the Conjunctival Sac Fluid of Patients upon Photorefractive Keratectomy
2015-01-01 Tisato, V; Perri, P; Rimondi, Erika; Melloni, E; Lamberti, G; Milani, D; Secchiero, P; Zauli, G.
Levels of TNF-related apoptosis-inducing ligand (TRAIL) show a long-term stability in the breast milk of mothers of preterm infants.
2013-01-01 G., Zauli; L., Monasta; Rimondi, Erika; L., Vecchi Brumatti; R., Davanzo; S., Demarini; P., Secchiero
MDM2 antagonist nutlin-3 suppresses the proliferation and differentiation of human pre-osteoclasts via a p53-dependent pathway.
2007-01-01 Zauli, G; Rimondi, Erika; Corallini, Federica; Fadda, R; Capitani, S; Secchiero, P.
Mevalonate kinase deficiency and squalene synthase inhibitor (TAK-475): The balance to extinguish the inflammation
2021-01-01 Rimondi, E.; Valencic, E.; Tommasini, A.; Secchiero, P.; Melloni, E.; Marcuzzi, A.
New Applications of JAK/STAT Inhibitors in Pediatrics: Current Use of Ruxolitinib
2022-01-01 Marcuzzi, Annalisa; Rimondi, Erika; Melloni, Elisabetta; Gonelli, Arianna; Grasso, Antonio Giacomo; Barbi, Egidio; Maximova, Natalia
Perifosine selectively induces cell cycle block and modulates retinoblastoma and E2F1 protein levels in p53 mutated leukemic cell lines.
2011-01-01 Celeghini, Claudio; Voltan, R.; Rimondi, Erika; Gattei, V.; Zauli, G.
Receptor activator of nuclear factor kappa B ligand(RANKL) modulates the expression of genes involved in apoptosis and cell cycle in human osteoclasts.
2007-01-01 Rimondi, Erika; Zweyer, Marina; Ricci, E; Fadda, R; Secchiero, P.